Madrigal Pharmaceuticals Inc (MDGL) — Cash Flow Reinvestment Rate
Madrigal Pharmaceuticals Inc (MDGL) has a Cash Flow Reinvestment Rate of 2.60x as of September 2025, reinvesting $207.85 Million (capex $857.00K plus investments $-207.00 Million) from operating cash flow of $79.85 Million. See Madrigal Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Madrigal Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2007)
Historical reinvestment intensity for Madrigal Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Madrigal Pharmaceuticals Inc (MDGL) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Madrigal Pharmaceuticals Inc (2007–2007)
Year-by-year capital reinvestment analysis for Madrigal Pharmaceuticals Inc. See MDGL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2007 | 0.09x | $2.35 Million | $27.22 Million | $2.35 Million | — |